(Q34479826)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Translational research--traffic on the bridge (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

R C Young

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

Biomedicine and Pharmacotherapy

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

9-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

565-571

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

Cancer care in women: will the practice of the 20th century be relevant in the 21st? Presidential address. International Gynecological Cancer Society, October 25, 2000.

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900144-5

7 January 2021

Ovarian cancer screening in the general population: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900144-5

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900144-5

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900144-5

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900144-5

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900144-5

7 January 2021

PIK3CA is implicated as an oncogene in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900144-5

7 January 2021

Selection of Active Drugs for Ovarian Cancer Based on CA-125 and Standard Response Rates in Phase II Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900144-5

7 January 2021

10.1016/S0753-3322(01)00144-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11769968%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference